Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

608P - Timing of surgery after neoadjuvant immunochemotherapy in non-small cell lung cancer is crucial for outcome

Date

07 Dec 2024

Session

Poster Display session

Presenters

Jiayi Wang

Citation

Annals of Oncology (2024) 35 (suppl_4): S1616-S1622. 10.1016/annonc/annonc1696

Authors

J. Wang

Author affiliations

  • Department Of Thoracic Surgery, Affiliated Hospital Of Xuzhou Medical University, The Affiliated Hospital of Xuzhou Medical University, 221000 - Xuzhou/CN

Resources

This content is available to ESMO members and event participants.

Abstract 608P

Background

Radical surgery after neoadjuvant immunochemotherapy treatment (NICT) is an important strategy for curing lung cancer clinically. Early surgery or delayed surgery could be responsible for reducing the therapeutic effect. Robust evidence on the optimal time interval between neoadjuvant therapy and surgery remains scant. The purpose of this study was to determine the relation between the timing of surgery after NICT and outcomes of surgery and pathological response.

Methods

The patients were divided into 3 groups depending on the wait time between completion of NICT and surgery in this retrospective study: short-interval group(SIG;<4 weeks),intermediate-interval group(IIG;4-6 weeks),and long-interval group(LIG;>6 weeks). The primary endpoints were disease-free survival (DFS) and overall survival (OS), while the secondary endpoints were pathological response, surgical outcomes, and postoperative complications. DFS and OS were estimated by the Kaplan-Meier analysis and the log-rank test.

Results

Among the 205 patients, 174 were male (84.9%), and the median (IQR) age was 62.0(56.0-68.0) years. There were 59 patients (28.8%) in the SIG, 108 patients (52.7%) in the IIG and 38 patients (18.5%) in the LIG. The median surgical interval was 3.6 weeks for the SIG, 4.7 weeks for the IIG and 6.7 weeks for the LIG. The overall pathological complete response (pCR) was 34.4%. When compared with the IIG, a significant correlation was observed between time interval and pCR in SIG (odds ratio[OR], 0.30; 95% CI, 0.14-0.63; P=0.002), expect LIG (OR, 0.67; 95% CI,0.31-1.46; P=0.317). Besides, there was a association between time interval and pleural adhesions in LIG (OR, 3.37; 95% CI, 1.38-8.27; P=0.008), except SIG (OR, 0.98; 95% CI, 0.37-2.62; P=0.974). The SIG was significantly associated with higher risk of recurrence (hazard ratio[HR], 1.96; 95% CI, 1.08-3.57; P=0.027), expect the LIG (HR, 1.90; 95% CI, 0.95-3.77; P=0.068). There was no significant difference in OS among the three groups.

Conclusions

Time intervals 4-6 weeks had the higher pCR rates and better DFS, and longer than 6 weeks were associated with increasing surgical complexity. Patients meeting surgical indications should try to receive surgery within 4-6 weeks after NICT.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The author.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.